Literature DB >> 27392748

Aberrant Pattern of Cytokeratin Expression in Olfactory Neuroblastoma: A Potential Diagnostic Pitfall.

Martina Mandarano1,2, Renato Colella3, Michele Giansanti3, Angelo Sidoni3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27392748      PMCID: PMC5429267          DOI: 10.1007/s12105-016-0743-4

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


× No keyword cloud information.
  4 in total

1.  Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression.

Authors:  P Argani; B Perez-Ordoñez; H Xiao; S M Caruana; A G Huvos; M Ladanyi
Journal:  Am J Surg Pathol       Date:  1998-04       Impact factor: 6.394

2.  Immunohistochemical characterization of human olfactory tissue.

Authors:  Eric H Holbrook; Enming Wu; William T Curry; Derrick T Lin; James E Schwob
Journal:  Laryngoscope       Date:  2011-08       Impact factor: 3.325

3.  Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study.

Authors:  T Hirose; B W Scheithauer; M B Lopes; H A Gerber; H J Altermatt; S G Harner; S R VandenBerg
Journal:  Cancer       Date:  1995-07-01       Impact factor: 6.860

Review 4.  Neuroendocrine Neoplasms of the Sinonasal Tract: Neuroendocrine Carcinomas and Olfactory Neuroblastoma.

Authors:  Ketan Shah; Bayardo Perez-Ordóñez
Journal:  Head Neck Pathol       Date:  2016-02-01
  4 in total
  3 in total

Review 1.  Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma.

Authors:  Diana Bell
Journal:  Head Neck Pathol       Date:  2018-02-09

Review 2.  Olfactory ganglioneuroblastoma in a dog: case report and literature review.

Authors:  Ashley M Romano; Chad B Frank
Journal:  J Vet Diagn Invest       Date:  2021-06-10       Impact factor: 1.569

Review 3.  Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside.

Authors:  Matt Lechner; Jacklyn Liu; Valerie J Lund
Journal:  Curr Oncol Rep       Date:  2020-07-29       Impact factor: 5.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.